Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
C-MER Medical HoldingsHKSE:03309 -0.58%83 Interest Coverage is 6.17 as of Dec. 2025, which is 5% below its 10-year median of 6.50. GuruFocus rates HKSE:03309 with a GF Score™ of 83/100 and a GF Value™ of HK$2.77 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 458 Healthcare Providers & Services companies, C-MER Medical Holdings ranks worse than 59.83% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. C-MER Medical Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was HK$69 Mil. C-MER Medical Holdings's Interest Expense for the
six
months ended in Dec. 2025 was HK$-11 Mil.
C-MER Medical Holdings's interest coverage for the quarter that ended in Dec. 2025 was 6.17.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for C-MER Medical Holdings's Interest Coverage or its related term are showing as below:
HKSE:03309'
s Interest Coverage Range Over the Past 10 Years
Min: 0.16 Med: 6.5 Max: 349.68
Current: 5.55
HKSE:03309's Interest Coverage is ranked worse than 59.83% of 458
companies
in the Healthcare Providers & Services industry
Industry Median: 7.835
vs HKSE:03309: 5.55
C-MER Medical Holdings (HKSE:03309) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
C-MER Medical Holdings Interest Coverage Related Terms
C-MER Medical Holdings Interest Coverage Historical Data
* Premium members only.
The historical data trend for C-MER Medical Holdings's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HKSE:03309 vs HCA, THC, DVA: Interest Coverage Comparison
For the Medical Care Facilities subindustry, C-MER Medical Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-MER Medical Holdings Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's Interest Coverage distribution charts can be found below:
* The bar in red indicates where C-MER Medical Holdings's Interest Coverage falls into.
C-MER Medical Holdings Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
C-MER Medical Holdings (HKSE:03309) has a Interest Coverage of 6.17 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on C-MER Medical Holdings and its competitors. This is near median its historical median of 6.50. Over the past decade, C-MER Medical Holdings' Interest Coverage has ranged from 0.16 to 349.68. According to the industry distribution chart, C-MER Medical Holdings ranks #274 out of 458 companies in the Healthcare Providers & Services industry, placing it in the top 59.8%.
Is C-MER Medical Holdings' Interest Coverage too high?
C-MER Medical Holdings' current Interest Coverage of 6.17 is near median its 10-year median of 6.50. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 349.68. The Healthcare Providers & Services industry median Interest Coverage is 7.84. C-MER Medical Holdings' value of 6.17 is 21.3% below this industry median. Based on the distribution chart, C-MER Medical Holdings ranks #274 out of 458 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' Interest Coverage compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, C-MER Medical Holdings ranks #274 out of 458 companies for Interest Coverage. This places C-MER Medical Holdings in the lower half of its industry. The industry median Interest Coverage is 7.84. C-MER Medical Holdings' value of 6.17 is 21.3% below this benchmark. Historically, C-MER Medical Holdings' own Interest Coverage has ranged from 0.16 to 349.68 over the past decade. While the company's 10-year median is 6.50 vs. the industry median of 7.84, C-MER Medical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.84, based on 458 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C-MER Medical Holdings's current Interest Coverage of 6.17 is 21.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on C-MER Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-MER Medical Holdings's current Interest Coverage is 6.17, which is near median its own 10-year median of 6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current Interest Coverage is 6.17, which is near median its 10-year median of 6.50 and 21.3% below the Healthcare Providers & Services industry median of 7.84. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current Interest Coverage is 6.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?
Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued.
The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77.
GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.
Key valuation signals for HKSE:03309:
Interest Coverage: 6.17 (near median its 10-year median of 6.50)
GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
Industry Position: 21.3% below the Healthcare Providers & Services median (#274 of 458)
No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score
Get the complete analysis for HKSE:03309
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03309 has been successfully added to your 
